BeiGene Engage Logo
Browse by category
  • Social Determinants of Health
  • Care Delivery
  • Policy Updates
Understanding EOM

Policy Updates

Understanding the Enhancing Oncology Model (EOM): Implications for Future Management

BeiGene Engage Steering Committee Members
Ray Bailey, RPh, Consultant
Formerly of Florida Cancer Specialists Victoria Nachar, PharmD, BCOP
Hematology Clinical Pharmacist Specialist
University of Michigan Rogel Cancer Center
Guest Speaker
Jay Weaver, PharmD, MPH
Former Chief Pharmacy Officer
Blue Cross Blue Shield of Kansas City

View Executive Summary
Strength in Numbers

Care Delivery

Strength in Numbers: How Oncology Practice Consolidation Is Impacting Care Delivery

BeiGene Engage Steering Committee Members
James Gilmore, PharmD
Chief Pharmacy and Clinical Services Officer
American Oncology Network (AON) Ray Bailey, RPh, Consultant
Formerly of Florida Cancer Specialists

View Executive Summary

Social Determinants of health

Healthcare Disparities in the Treatment of CLL/SLL: A Real-World Analysis of SEER Data

Guest Speaker
Adam S. Kittai, MD, Division of Hematology
Ohio State University Comprehensive Cancer Center

View Executive Summary
Optimizing Outcomes

Care Delivery

Optimizing Outcomes in the Management of CLL: The Evolving Role of the Clinical Pharmacist

BeiGene Engage Steering Committee Members
John Allan, MD, Hematology/Oncology Victoria Nachar, PharmD, BCOP
Hematology Clinical Pharmacist Specialist
University of Michigan Rogel Cancer Center

View Executive Summary